Bright Minds Biosciences (DRUG) Return on Equity [ROE] (2023 - 2026)
Bright Minds Biosciences' Return on Equity [ROE] was 1.85% in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 8.93 percentage points from 10.78% a year earlier and down 4.83 percentage points from the prior quarter.
Powered by 
Analysis
Bright Minds Biosciences (DRUG) Return on Equity [ROE] (2023 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Return on Equity [ROE] at Bright Minds Biosciences came in at -27.88%, up 18.08 percentage points from FY2024.
- Return on Equity [ROE] has now increased for three consecutive fiscal years, with a five-year change of +96.02 percentage points (FY2020 to FY2025).
- In earlier fiscal years, Return on Equity [ROE] was -45.96% in FY2024 (+37.19 pp), -83.15% in FY2023 (+99301791.86 pp), -99301875.00% in FY2022 (-13171189.52 pp) and -86130685.48% in FY2021 (-86130561.58 pp).
- Quarterly Return on Equity [ROE] has moved between -185531861.87% (fiscal Q3 2023) and 10.78% (fiscal Q3 2025) over five years.
- Compared with a year earlier, Return on Equity [ROE] was higher in five of the last eight quarters, with an average year-over-year change of +62.35 percentage points.
- The best year-over-year quarter for Return on Equity [ROE] over five years was fiscal Q3 2024 (a gain of 185531720.33 percentage points); the worst was fiscal Q3 2026 (a drop of 8.93 percentage points).
- Per Business Quant data, DRUG's Return on Equity [ROE] in the three fiscal quarters before Q3 2026 was 6.68% (Q2 2026), -14.18% (Q1 2026) and -5.61% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Bright Minds Biosciences | 172.65 Mn | -390.95 Mn | - | -8.37% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -8.37% |
| Mar 31, 2026 | -14.22% |
| Dec 31, 2025 | -23.88% |
| Sep 30, 2025 | -14.08% |
| Jun 30, 2025 | -9.92% |
| Mar 31, 2025 | -3.88% |
| Dec 31, 2024 | -2.40% |
| Sep 30, 2024 | -13.90% |
| Jun 30, 2024 | -10.24% |
| Mar 31, 2024 | -14.85% |
| Dec 31, 2023 | -31.73% |
| Sep 30, 2023 | -35.84% |
| Jun 30, 2023 | -26.02% |
| Mar 31, 2023 | -30.41% |
API Access
Bright Minds Biosciences Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=DRUG&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "DRUG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=DRUG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();